Pricing Log in Create free account

Enanta Pharmaceuticals, Inc. (ENTA) vs Prelude Therapeutics Incorporated (PRLD)

Enanta Pharmaceuticals, Inc. and Prelude Therapeutics Incorporated are both Biotechnology companies. Enanta Pharmaceuticals, Inc. and Prelude Therapeutics Incorporated are of similar size ($293.6M and $283.7M). Enanta Pharmaceuticals, Inc. has the higher net margin (−96.9% vs −269.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Enanta Pharmaceuticals, Inc. leads on 7 and Prelude Therapeutics Incorporated on 6.

Valuation

Metric ENTA PRLD Biotechnology median
P/E n/m n/m 10.60
P/S 4.90 15.80 9.40
P/B 3.17 2.65 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 2.00 9.03 9.02
Earnings yield (21.91%) (20.28%) (32.88%)
Free cash flow yield (11.54%) (9.41%) (23.13%)

Profitability

Metric ENTA PRLD Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (89.99%) (300.56%) 0.00%
Net margin (96.89%) (269.75%) 0.00%
Free cash flow margin (56.60%) (148.30%) 0.00%
Return on equity (70.12%) (57.73%) (51.96%)
Return on assets (21.15%) (39.76%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENTA PRLD Biotechnology median
Revenue growth (TTM) 0.70% — 6.76%
EPS growth (last fiscal year) 29.93% 23.21% 29.88%
Revenue growth, 5-year CAGR (11.81%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENTA PRLD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.76 4.07 4.97
Net debt to EBITDA 2.35 1.00 1.01

Dividend

Metric ENTA PRLD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ENTA PRLD Biotechnology median
Market cap 293.59m 283.70m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack